Dr Clark is a Senior Lecturer at the School of Biomedical Sciences where he is Head of the Peptide Chemical Biology Lab. He completed his PhD in 2000 at the UQ Chemistry Department studying marine natural products chemistry and chemical ecology with Prof. Mary Garson. He then shifted his research focus towards peptide chemistry, structural biology and drug design when he was recruited to the lab of Prof. David Craik at the IMB. His current research focus is the development of technologies to stabilise peptide therapeutics and the elucidation of the structure/function activity of bioactive peptides.
Journal Article: Special Issue in Honor of Professor Mary Garson AM
Blanchfield, Joanne T., Nonato, Maribel G. and Clark, Richard J. (2023). Special Issue in Honor of Professor Mary Garson AM. Journal of Natural Products, 86 (3), 473-474. doi: 10.1021/acs.jnatprod.3c00088
Journal Article: TLQP-21 is a low potency partial C3aR activator on human primary macrophages
Li, Xaria X., Lee, John D., Lee, Han S., Clark, Richard J. and Woodruff, Trent M. (2023). TLQP-21 is a low potency partial C3aR activator on human primary macrophages. Frontiers in Immunology, 14 1086673, 1-10. doi: 10.3389/fimmu.2023.1086673
Conference Publication: WS1.4: Biostimulation of bacteria for streamlined identification of new antimicrobial compounds
Mirzaee, Hooman, Ariens, Emily, Booth, James, Carvalhais, Lilia C., Blaskovich, Mark A.T., Clark, Richard J. and Schenk, Peer M. (2022). WS1.4: Biostimulation of bacteria for streamlined identification of new antimicrobial compounds. 32nd International Congress of Antimicrobial Chemotherapy (ICC), Perth, WA Australia, 27 – 30 November 2022. Amsterdam, Netherlands: Elsevier BV. doi: 10.1016/s2213-7165(22)00272-7
Making peptides orally bioavailable
(2022–2025) ARC Discovery Projects
Making peptide drugs orally bioavailable
(2022–2024) NHMRC IDEAS Grants
(2022–2024) NHMRC Development Grant
Design and development of peptide ligands targeting the complement system
Doctor Philosophy
Making peptide drugs orally bioavailable
Doctor Philosophy
Design and Development of Peptides Targeting the C5a-C5aR Interaction
(2022) Doctor Philosophy
Designing novel conotoxins with therapeutic potential
Conotoxins, with their exquisite specificity and potency have recently created much excitement as drug leads for the treatment of chronic pain. For example, the conotoxin MVIIA (also known as Ziconotide or Prialt) has been approved for use in the U.S. and Europe for the treatment of pain and several other conotoxins have entered clinical trials. In addition, a number of conotoxins have played a critical role in dissecting the molecular mechanisms of ion channel and transporter functions in the nervous system.
There are projects available in the design of novel conotoxins that target specific receptors involved in pain.
Development of stable peptide-based drugs for the treatment of iron disorders
Hepcidin is the principal iron-regulatory hormone and the key mediator of iron overload (haemochromatosis) and anaemia of inflammation. This research project involves two development streams of peptide design, synthesis and structure/function analysis. The first stream will focus on the specific residues important for biological activity of hepcidin and the mutation of these residues to improve activity. The second stream will involve the development of stabilised analogues of native hepcidin. The two streams will coalesce during the final round of development to produce a series of novel cyclic hepcidin drug leads.
Molecular engineering of Conus peptides as therapeutic leads
Daniel, James T. and Clark, Richard J. (2017). Molecular engineering of Conus peptides as therapeutic leads. Peptides and peptide-based biomaterials and their biomedical applications. (pp. 229-254) edited by Anwar Sunna, Andrew Care and Peter L. Bergquist. Cham, Switzerland: Springer. doi: 10.1007/978-3-319-66095-0_10
NMR-based screening and drug discovery
Craik, David J., Smith, Philippa A. and Clark, Richard James (2010). NMR-based screening and drug discovery. Burger's medicinal chemistry, drug discovery, and development. (pp. 359-437) edited by Donald J. Abraham, David P. Rotella and Alfred Burger. Hoboken, N.J.: Wiley. doi: 10.1002/0471266949
Structure-based Drug Design and NMR-based screening
Craik, D. J. and Clark, R. J. (2008). Structure-based Drug Design and NMR-based screening. Pharmacology from drug development to gene therapy. (pp. 225-313) edited by R. A. Meyers. Weinheim: Wiley-VCH Verlag GMBH & Co.
Structure-based drug design and NMR-based screening
Craik, D. J. and Clark, R. J. (2005). Structure-based drug design and NMR-based screening. Encyclopdeia of Molecular Cell Biology and Molecular Medicine. (pp. 517-605) edited by Robert A Meyers. Germany: Wiley-VCH.
Craik, D. J. and Clark, R. J. (2003). NMR and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery, Vol 1, Drug Discovery. (pp. 507-582) edited by Donald J Abraham. USA: John Wiley & Sons. doi: 10.1002/0471266949.bmc011
Special Issue in Honor of Professor Mary Garson AM
Blanchfield, Joanne T., Nonato, Maribel G. and Clark, Richard J. (2023). Special Issue in Honor of Professor Mary Garson AM. Journal of Natural Products, 86 (3), 473-474. doi: 10.1021/acs.jnatprod.3c00088
TLQP-21 is a low potency partial C3aR activator on human primary macrophages
Li, Xaria X., Lee, John D., Lee, Han S., Clark, Richard J. and Woodruff, Trent M. (2023). TLQP-21 is a low potency partial C3aR activator on human primary macrophages. Frontiers in Immunology, 14 1086673, 1-10. doi: 10.3389/fimmu.2023.1086673
Author Correction: Tick holocyclotoxins trigger host paralysis by presynaptic inhibition
Chand, Kirat K., Lee, Kah Meng, Lavidis, Nickolas A., Rodriguez-Valle, Manuel, Ijaz, Hina, Koehbach, Johannes, Clark, Richard J., Lew-Tabor, Ala and Noakes, Peter G. (2022). Author Correction: Tick holocyclotoxins trigger host paralysis by presynaptic inhibition. Scientific Reports, 12 (1) 20636, 1-1. doi: 10.1038/s41598-022-24528-4
Engineering peptide inhibitors of the HFE–transferrin receptor 1 complex
Goncalves Monteiro, Daniela Goncalves, Rishi, Gautam, Gorman, Declan M., Burnet, Guillaume, Aliyanto, Randy, Rosengren, K. Johan, Frazer, David M., Subramaniam, V. Nathan and Clark, Richard J. (2022). Engineering peptide inhibitors of the HFE–transferrin receptor 1 complex. Molecules, 27 (19) 6581, 1-13. doi: 10.3390/molecules27196581
SARS-CoV-2 triggers complement activation through interactions with heparan sulfate
Lo, Martin W., Amarilla, Alberto A., Lee, John D., Albornoz, Eduardo A., Modhiran, Naphak, Clark, Richard J., Ferro, Vito, Chhabra, Mohit, Khromykh, Alexander A., Watterson, Daniel and Woodruff, Trent M. (2022). SARS-CoV-2 triggers complement activation through interactions with heparan sulfate. Clinical and Translational Immunology, 11 (8) e1413, e1413. doi: 10.1002/cti2.1413
Moral‐Sanz, Javier, Fernandez‐Rojo, Manuel A., Colmenarejo, Gonzalo, Kurdyukov, Sergey, Brust, Andreas, Ragnarsson, Lotten, Andersson, Åsa, Vila, Sabela F., Cabezas‐Sainz, Pablo, Wilhelm, Patrick, Vela‐Sebastian, Ana, Fernández‐Carrasco, Isabel, Chin, Yanni K. Y., López‐ Mancheño, Yaiza, Smallwood, Taylor B., Clark, Richard J., Fry, Bryan G., King, Glenn F., Ramm, Grant A., Alewood, Paul F., Lewis, Richard J., Mulvenna, Jason P., Boyle, Glen M., Sanchez, Laura E., Neely, G. Gregory, Miles, John J. and Ikonomopoulou, Maria P. (2022). The structural conformation of the tachykinin domain drives the anti‐tumoral activity of an octopus peptide in melanoma BRAF V600E. British Journal of Pharmacology, 179 (20), 4878-4896. doi: 10.1111/bph.15923
Niyonzima, Nathalie, Rahman, Jubayer, Kunz, Natalia, West, Erin E., Freiwald, Tilo, Desai, Jigar V., Merle, Nicolas S., Gidon, Alexandre, Sporsheim, Bjørnar, Lionakis, Michail S., Evensen, Kristin, Lindberg, Beate, Skagen, Karolina, Skjelland, Mona, Singh, Parul, Haug, Markus, Ruseva, Marieta M., Kolev, Martin, Bibby, Jack, Marshall, Olivia, O’Brien, Brett, Deeks, Nigel, Afzali, Behdad, Clark, Richard J., Woodruff, Trent M., Pryor, Milton, Yang, Zhi-Hong, Remaley, Alan T., Mollnes, Tom E. ... Kemper, Claudia (2021). Mitochondrial C5aR1 activity in macrophages controls IL-1β production underlying sterile inflammation. Science Immunology, 6 (66) eabf2489, eabf2489. doi: 10.1126/sciimmunol.abf2489
In vivo pharmacodynamic method to assess complement C5a receptor antagonist efficacy
Cui, Cedric S., Kumar, Vinod, Gorman, Declan M., Clark, Richard J., Lee, John D. and Woodruff, Trent M. (2021). In vivo pharmacodynamic method to assess complement C5a receptor antagonist efficacy. ACS Pharmacology and Translational Science, 5 (1) acsptsci.1c00227, 41-51. doi: 10.1021/acsptsci.1c00227
Payne, Colton D., Vadlamani, Grishma, Hajiaghaalipour, Fatemeh, Muhammad, Taj, Fisher, Mark F., Andersson, Håkan S., Göransson, Ulf, Clark, Richard J., Bond, Charles S., Mylne, Joshua S. and Rosengren, K. Johan (2021). Solution NMR and racemic crystallography provide insights into a novel structural class of cyclic plant peptides. RSC Chemical Biology, 2 (6), 1682-1691. doi: 10.1039/d1cb00155h
Unexpected off-target activities for recombinant C5a in human macrophages
Li, Xaria X., Gorman, Declan M., Lee, John D., Clark, Richard J. and Woodruff, Trent M. (2021). Unexpected off-target activities for recombinant C5a in human macrophages. Journal of Immunology, 208 (1), 133-142. doi: 10.4049/jimmunol.2100444
Biostimulation of bacteria in liquid culture for identification of new antimicrobial compounds
Mirzaee, Hooman, Ariens, Emily, Blaskovich, Mark A. T., Clark, Richard J. and Schenk, Peer M. (2021). Biostimulation of bacteria in liquid culture for identification of new antimicrobial compounds. Pharmaceuticals, 14 (12) 1232, 1232. doi: 10.3390/ph14121232
Clark, Richard J., Phan, Thanh Huyen, Song, Angela, Ouellette, André J., Conibear, Anne C. and Rosengren, K. Johan (2021). A conserved β‐bulge glycine residue facilitates folding and increases stability of the mouse α‐defensin cryptdin‐4. Peptide Science, 114 (1) e24250. doi: 10.1002/pep2.24250
Gorman, Declan M., Li, Xaria X., Payne, Colton D., Cui, Cedric S., Lee, John D., Rosengren, K. Johan, Woodruff, Trent M. and Clark, Richard J. (2021). Development of synthetic human and mouse C5a: application to binding and functional assays in vitro and in vivo. ACS Pharmacology and Translational Science, 4 (6) acsptsci.1c00199, 1808-1817. doi: 10.1021/acsptsci.1c00199
Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity
Gorman, Declan M., Li, Xaria X., Lee, John D., Fung, Jenny N., Cui, Cedric S., Lee, Han Siean, Rolfe, Barbara E., Woodruff, Trent M. and Clark, Richard J. (2021). Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity. Journal of Medicinal Chemistry, 64 (22) acs.jmedchem.1c01174, 16598-16608. doi: 10.1021/acs.jmedchem.1c01174
Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonists
Li, Xaria X., Clark, Richard J. and Woodruff, Trent M. (2021). Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonists. International Immunopharmacology, 100 108074, 108074. doi: 10.1016/j.intimp.2021.108074
LEAP-2: an emerging endogenous ghrelin receptor antagonist in the pathophysiology of obesity
Lu, Xuehan, Huang, Lili, Huang, Zhengxiang, Feng, Dandan, Clark, Richard J. and Chen, Chen (2021). LEAP-2: an emerging endogenous ghrelin receptor antagonist in the pathophysiology of obesity. Frontiers in Endocrinology, 12 717544, 717544. doi: 10.3389/fendo.2021.717544
Smallwood, Taylor B., Navarro, Severine, Cristofori-Armstrong, Ben, Watkins, Thomas S., Tungatt, Katie, Ryan, Rachael Y.M., Haigh, Oscar L., Lutzky, Viviana P., Mulvenna, Jason P., Rosengren, K. Johan, Loukas, Alex, Miles, John J. and Clark, Richard J. (2021). Synthetic hookworm-derived peptides are potent modulators of primary human immune cell function that protect against experimental colitis in vivo. Journal of Biological Chemistry, 297 (1) 100834, 1-14. doi: 10.1016/j.jbc.2021.100834
Muratspahić, Edin, Tomašević, Nataša, Koehbach, Johannes, Duerrauer, Leopold, Hadžić, Seid, Castro, Joel, Schober, Gudrun, Sideromenos, Spyridon, Clark, Richard J., Brierley, Stuart M., Craik, David J. and Gruber, Christian W. (2021). Design of a stable cyclic peptide analgesic derived from sunflower seeds that targets the κ-opioid receptor for the treatment of chronic abdominal pain. Journal of Medicinal Chemistry, 64 (13) acs.jmedchem.1c00158, 9042-9055. doi: 10.1021/acs.jmedchem.1c00158
Poth, Aaron G., Chiu, Francis C.K., Stalmans, Sofie, Hamilton, Brett R., Huang, Yen-Hua, Shackleford, David M., Patil, Rahul, Le, Thao T., Kan, Meng-Wei, Durek, Thomas, Wynendaele, Evelien, De Spiegeleer, Bart, Powell, Andrew K., Venter, Deon J., Clark, Richard J., Charman, Susan A. and Craik, David J. (2021). Effects of backbone cyclization on the pharmacokinetics and drug efficiency of the orally active analgesic conotoxin cVc1.1. Medicine in Drug Discovery, 10 100087, 1-10. doi: 10.1016/j.medidd.2021.100087
Advances in venom peptide drug discovery: where are we at and where are we heading?
Smallwood, Taylor B. and Clark, Richard J. (2021). Advances in venom peptide drug discovery: where are we at and where are we heading?. Expert Opinion on Drug Discovery, 16 (10) 17460441.2021.1922386, 1-11. doi: 10.1080/17460441.2021.1922386
A chameleonic macrocyclic peptide with drug delivery applications
Payne, Colton D., Franke, Bastian, Fisher, Mark F., Hajiaghaalipour, Fatemeh, McAleese, Courtney E., Song, Angela, Eliasson, Carl, Zhang, Jingjing, Jayasena, Achala S., Vadlamani, Grishma, Clark, Richard J., Minchin, Rodney F., Mylne, Joshua S. and Rosengren, K. Johan (2021). A chameleonic macrocyclic peptide with drug delivery applications. Chemical Science, 12 (19), 6670-6683. doi: 10.1039/d1sc00692d
Moral-Sanz, Javier, Fernandez-Rojo, Manuel A., Potriquet, Jeremy, Mukhopadhyay, Pamela, Brust, Andreas, Wilhelm, Patrick, Smallwood, Taylor B., Clark, Richard J., Fry, Bryan G., Alewood, Paul F., Waddell, Nicola, Miles, John J., Mulvenna, Jason P. and Ikonomopoulou, Maria P. (2021). ERK and mTORC1 inhibitors enhance the anti-cancer capacity of the octpep-1 venom-derived peptide in melanoma BRAF(V600E) mutations. Toxins, 13 (2) 146, 1-19. doi: 10.3390/toxins13020146
Pursuing orally bioavailable hepcidin analogues via cyclic N-methylated mini-hepcidins
Goncalves Monteiro, Daniela, van Dijk, Johannes W. A., Aliyanto, Randy, Fung, Eileen, Nemeth, Elizabeta, Ganz, Tomas, Rosengren, Johan and Clark, Richard J. (2021). Pursuing orally bioavailable hepcidin analogues via cyclic N-methylated mini-hepcidins. Biomedicines, 9 (2) 164, 1-14. doi: 10.3390/biomedicines9020164
The “C3aR Antagonist” SB290157 is a partial C5aR2 agonist
Li, Xaria X., Kumar, Vinod, Clark, Richard J., Lee, John D. and Woodruff, Trent M. (2021). The “C3aR Antagonist” SB290157 is a partial C5aR2 agonist. Frontiers in Pharmacology, 11 591398, 591398. doi: 10.3389/fphar.2020.591398
Chemical synthesis and characterisation of the complement C5 inhibitory peptide zilucoplan
Gorman, Declan M., Lee, John, Payne, Colton D., Woodruff, Trent M. and Clark, Richard J. (2021). Chemical synthesis and characterisation of the complement C5 inhibitory peptide zilucoplan. Amino Acids, 53 (1), 143-147. doi: 10.1007/s00726-020-02921-5
Defining the familial fold of the vicilin-buried peptide family
Payne, Colton D., Vadlamani, Grishma, Fisher, Mark F., Zhang, Jingjing, Clark, Richard J., Mylne, Joshua S. and Rosengren, K. Johan (2020). Defining the familial fold of the vicilin-buried peptide family. Journal of Natural Products, 83 (10), 3030-3040. doi: 10.1021/acs.jnatprod.0c00594
Exploring the use of helicogenic amino acids for optimising single chain relaxin-3 peptide agonists
Lee, Han Siean, Wang, Shu Hui, Daniel, James T., Hossain, Mohammed Akhter, Clark, Richard J., Bathgate, Ross A. D. and Rosengren, K. Johan (2020). Exploring the use of helicogenic amino acids for optimising single chain relaxin-3 peptide agonists. Biomedicines, 8 (10) 415, 1-16. doi: 10.3390/biomedicines8100415
Li, Xaria X., Lee, John D., Massey, Nicholas L., Guan, Carolyn, Robertson, Avril A. B., Clark, Richard J. and Woodruff, Trent M. (2020). Pharmacological characterisation of small molecule C5aR1 inhibitors in human cells reveals biased activities for signalling and function. Biochemical Pharmacology, 180 114156, 114156. doi: 10.1016/j.bcp.2020.114156
C5aR2 activation broadly modulates the signaling and function of primary human macrophages
Li, Xaria X., Clark, Richard J. and Woodruff, Trent M. (2020). C5aR2 activation broadly modulates the signaling and function of primary human macrophages. Journal of Immunology, 205 (4), 1-11. doi: 10.4049/jimmunol.2000407
Development of relaxin-3 agonists and antagonists based on grafted disulfide-stabilized scaffolds
Lee, Han Siean, Postan, Michael, Song, Angela, Clark, Richard J., Bathgate, Ross A. D., Haugaard-Kedström, Linda M. and Rosengren, K. Johan (2020). Development of relaxin-3 agonists and antagonists based on grafted disulfide-stabilized scaffolds. Frontiers in Chemistry, 8 87, 87. doi: 10.3389/fchem.2020.00087
Preclinical pharmacokinetics of complement C5a receptor antagonists PMX53 and PMX205 in mice
Kumar, Vinod, Lee, John D., Clark, Richard J., Noakes, Peter G., Taylor, Stephen M. and Woodruff, Trent M. (2020). Preclinical pharmacokinetics of complement C5a receptor antagonists PMX53 and PMX205 in mice. ACS Omega, 5 (5) acsomega.9b03735, 2345-2354. doi: 10.1021/acsomega.9b03735
El Hamdaoui, Yamina, Wu, Xiaosa, Clark, Richard J., Giribaldi, Julien, Anangi, Raveendra, Craik, David J., King, Glenn F., Dutertre, Sebastien, Kaas, Quentin, Herzig, Volker and Nicke, Annette (2019). Periplasmic expression of 4/7 alpha-conotoxin TxIA analogs in E. coli favors ribbon isomer formation suggestion of a binding mode at the α7 nAChR. Frontiers in Pharmacology, 10 (MAY) 577, 577. doi: 10.3389/fphar.2019.00577
Discovery of peptide probes to modulate oxytocin-type receptors of insects
Keov, Peter, Liutkevičiūtė, Zita, Hellinger, Roland, Clark, Richard J. and Gruber, Christian W. (2018). Discovery of peptide probes to modulate oxytocin-type receptors of insects. Scientific reports, 8 (1) 10020, 10020. doi: 10.1038/s41598-018-28380-3
Sadeghi, Mahsa, Carstens, Bodil B., Callaghan, Brid P., Daniel, James T., Tae, Han Shen, O'Donnell, Tracey, Castro, Joel, Brierley, Stuart M., Adams, David J., Craik, David J. and Clark, Richard J. (2018). Structure-activity studies reveal the molecular basis for GABAB-receptor mediated inhibition of high voltage-activated calcium channels by α-conotoxin Vc1.1. ACS Chemical Biology, 13 (6), 1577-1587. doi: 10.1021/acschembio.8b00190
Kumar, Vinod, Lee, John D., Clark, Richard J. and Woodruff, Trent M. (2018). Development and validation of a LC-MS/MS assay for pharmacokinetic studies of complement C5a receptor antagonists PMX53 and PMX205 in mice. Scientific Reports, 8 (1) 8101, 8101. doi: 10.1038/s41598-018-26387-4
Peptide mimic for influenza vaccination using nonnatural combinatorial chemistry
Miles, John J., Tan, Mai Ping, Dolton, Garry, Edwards, Emily S. J., Galloway, Sarah A. E., Laugel, Bruno, Clement, Mathew, Makinde, Julia, Ladell, Kristin, Matthews, Katherine K., Watkins, Thomas S., Tungatt, Katie, Wong, Yide, Lee, Han Siean, Clark, Richard J., Pentier, Johanne M., Attaf, Meriem, Lissina, Anya, Ager, Ann, Gallimore, Awen, Rizkallah, Pierre J., Gras, Stephanie, Rossjohn, Jamie, Burrows, Scott R., Cole, David K., Price, David A. and Sewell, Andrew K. (2018). Peptide mimic for influenza vaccination using nonnatural combinatorial chemistry. Journal of Clinical Investigation, 128 (4), 1569-1580. doi: 10.1172/JCI91512
Transcriptome and toxin family analysis of the paralysis tick, Ixodes holocyclus
Rodriguez-Valle, Manuel, Moolhuijzen, Paula, Barrero, Roberto A., Ong, Chian Teng, Busch, Greta, Karbanowicz, Thomas, Booth, Mitchell, Clark, Richard, Koehbach, Johannes, Ijaz, Hina, Broady, Kevin, Agnew, Kim, Knowles, Aleta G., Bellgard, Matthew I. and Tabor, Ala E. (2018). Transcriptome and toxin family analysis of the paralysis tick, Ixodes holocyclus. International Journal for Parasitology, 48 (1), 71-82. doi: 10.1016/j.ijpara.2017.07.007
G-Protein Coupled Receptors Targeted by Analgesic Venom Peptides
Daniel, James T. and Clark, Richard J. (2017). G-Protein Coupled Receptors Targeted by Analgesic Venom Peptides. Toxins, 9 (11) 372, 1-26. doi: 10.3390/toxins9110372
Helminth immunomodulation in autoimmune disease
Smallwood, Taylor B., Giacomin, Paul R., Loukas, Alex, Mulvenna, Jason P., Clark, Richard J. and Miles, John J. (2017). Helminth immunomodulation in autoimmune disease. Frontiers in Immunology, 8 (APR) 453, 453. doi: 10.3389/fimmu.2017.00453
Carstens, Bodil B., Swedberg, Joakim, Berecki, Geza, Adams, David J., Craik, David J. and Clark, Richard J. (2016). Effects of linker sequence modifications on the structure, stability and biological activity of a cyclic α-conotoxin. Biopolymers, 106 (6), 864-875. doi: 10.1002/bip.22848
Unveiling the diversity of cyclotides by combining peptidome and transcriptome analysis
Koehbach, Johannes and Clark, Richard J. (2016). Unveiling the diversity of cyclotides by combining peptidome and transcriptome analysis. Biopolymers, 106 (6), 774-783. doi: 10.1002/bip.22858
Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signalling
Croker, Daniel E., Monk, Peter N., Halai, Reena, Kaeslin, Geraldine, Schofield, Zoe, Wu, Mike C. L., Clark, Richard J., Blaskovich, Mark A. T., Morikis, Dimitrios, Floudas, Christodoulos A., Cooper, Matthew and Woodruff, Trent M. (2016). Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signalling. Immunology and Cell Biology, 94 (8), 787-795. doi: 10.1038/icb.2016.43
Zhang, Jing, Woodruff, Trent M., Clark, Richard J., Martin, Darren J. and Minchin, Rodney F. (2016). Release of bioactive peptides from polyurethane films in vitro and in vivo: Effect of polymer composition. Acta Biomaterialia, 41, 264-272. doi: 10.1016/j.actbio.2016.05.034
The N-terminal pro-domain of the kalata B1 cyclotide precursor is intrinsically unstructured
Daly, Norelle L., Gunasekera, Sunithi, Clark, Richard J., Lin, Feng, Wade, John D., Anderson, Marilyn and Craik, David J. (2016). The N-terminal pro-domain of the kalata B1 cyclotide precursor is intrinsically unstructured. Biopolymers, 106 (6), 825-833. doi: 10.1002/bip.22977
Tick holocyclotoxins trigger host paralysis by presynaptic inhibition
Chand, Kirat K., Lee, Kah Meng, Lavidis, Nickolas A., Rodriguez-Valle, Manuel, Ijaz, Hina, Koehbach, Johannes, Clark, Richard J., Lew-Tabor, Ala and Noakes, Peter G. (2016). Tick holocyclotoxins trigger host paralysis by presynaptic inhibition. Scientific Reports, 6 (1) 29446, 29446. doi: 10.1038/srep29446
Carstens, Bodil B., Berecki, Géza, Daniel, James T., Lee, Han Siean, Jackson, Kathryn A. V., Tae, Han-Shen, Sadeghi, Mahsa, Castro, Joel, O'Donnell, Tracy, Deiteren, Annemie, Brierley, Stuart M., Craik, David J., Adams, David J. and Clark, Richard J. (2016). Structure-Activity Studies of Cysteine-Rich α-Conotoxins that Inhibit High-Voltage-Activated Calcium Channels via GABAB Receptor Activation Reveal a Minimal Functional Motif. Angewandte Chemie, 128 (15), 4770-4774. doi: 10.1002/ange.201600297
Carstens, Bodil B., Berecki, Geza, Daniel, James T., Lee, Han Siean, Jackson, Kathryn A. V., Tae, Han-Shen, Sadeghi, Mahsa, Castro, Joel, O'Donnell, Tracy, Deiteren, Annemie, Brierley, Stuart M., Craik, David J., Adams, David J. and Clark, Richard J. (2016). Structure-Activity Studies of Cysteine-Rich α-Conotoxins that Inhibit High Voltage-Activated Calcium Channels via GABAB Receptor Activation Reveal a Minimal Functional Motif. Angewandte Chemie - International Edition, 55 (15), 4692-4696. doi: 10.1002/anie.201600297
Transforming conotoxins into cyclotides: backbone cyclization of P-superfamily conotoxins
Akcan, Muharrem, Clark, Richard J., Daly, Norelle L., Conibear, Anne C., de Faoite, Andrew, Heghinian, Mari D., Sahil, Talwar, Adams, David J., Mari, Frank and Craik, David J. (2015). Transforming conotoxins into cyclotides: backbone cyclization of P-superfamily conotoxins. Peptide Science, 104 (6), 682-692. doi: 10.1002/bip.22699
Carstens, Bodil B., Rosengren, K. Johan, Gunasekera, Sunithi, Schempp, Stefanie, Bohlin, Lars, Dahlstrom, Mia, Clark, Richard J. and Goransson, Ulf (2015). Isolation, characterization, and synthesis of the barrettides: disulfide-containing peptides from the marine sponge Geodia barretti. Journal of Natural Products, 78 (8), 1886-1893. doi: 10.1021/acs.jnatprod.5b00210
Hellinger, Roland, Koehbach, Johannes, Puigpinos, Albert, Clark, Richard J., Tarrago, Teresa, Giralt, Ernest and Gruber, Christian W. (2015). Inhibition of human prolyl oligopeptidase activity by the cyclotide psysol 2 isolated from Psychotria solitudinum. Journal of Natural Products, 78 (5), 1073-1082. doi: 10.1021/np501061t
Malik, U., Silva, O. N., Fensterseifer, I. C. M., Chan, A., Clark, R. J., Franco, O. L., Daly, N. L. and Craik, D. J. (2015). In vivo efficacy of anuran rypsin inhibitory peptides against Staphylococcal Skin infection and the impact of peptide cyclization. Antimicrobial Agents and Chemotherapy, 59 (4), 2113-2121. doi: 10.1128/AAC.04324-14
Kompella, Shiva N., Hung, Andrew, Clark, Richard J., Mari, Frank and Adams, David J. (2015). Alanine scan ofα-conotoxin regIIA reveals a selective α3β4 nicotinic acetylcholine receptor antagonist. Journal of Biological Chemistry, 290 (2), 1039-1048. doi: 10.1074/jbc.M114.605592
Berecki, Géza, McArthur, Jeffrey R., Cuny, Hartmut, Clark, Richard J. and Adams, David J. (2014). Differential Cav2.1 and Cav2.3 channel inhibition by baclofen and α-conotoxin Vc1.1 via GABAB receptor activation. Journal of General Physiology, 143 (4), 465-479. doi: 10.1085/jgp.201311104
Akcan, Muharrem, Stroud, Mark R., Hansen, Stacey J., Clark, Richard J., Daly, Norelle L., Craik, David J. and Olson, James M. (2013). Erratum: Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapy (Journal of Medicinal Chemistry (2011) 54 (782-787) DOI: 10.1021/jm101018r). Journal of Medicinal Chemistry, 56 (23), 9807-9807. doi: 10.1021/jm4016119
Grishin, Anton A., Cuny, Hartmut, Hung, Andrew, Clark, Richard J., Brust, Andreas, Akondi, Kalyana, Alewood, Paul F., Craik, David J. and Adams, David J. (2013). Identifying key amino acid residues that affect alpha-conotoxin AuIB inhibition of alpha3beta4 nicotinic acetylcholine receptors. Journal of Biological Chemistry, 288 (48), 34428-34442. doi: 10.1074/jbc.M113.512582
Novel inhibitor cystine knot peptides from momordica charantia
He, Wen-Jun, Chan, Lai Yue, Clark, Richard J., Tang, Jun, Zeng, Guang-Zhi, Franco, Octavio L., Cantacessi, Cinzia, Craik, David J., Daly, Norelle L. and Tan, Ning-Hua (2013). Novel inhibitor cystine knot peptides from momordica charantia. PLoS ONE, 8 (10) e75334, e75334.1-e75334.10. doi: 10.1371/journal.pone.0075334
Clark, Richard J., Preza, Gloria C., Tan, Chia Chia, van Dijk, Johannes W. A., Fung, Eileen, Nemeth, Elizabeta, Ganz, Tomas and Craik, David J. (2013). Design, synthesis and characterisation of cyclic analogues of the iron regulatory peptide hormone hepcidin. Biopolymers: Peptide Science, 100 (5), 519-526. doi: 10.1002/bip.22350
Cyclization of conotoxins to improve their biopharmaceutical properties
Clark, Richard J., Akcan, Muharrem, Kaas, Quentin, Daly, Norelle L. and Craik, David J. (2012). Cyclization of conotoxins to improve their biopharmaceutical properties. Toxicon, 59 (4), 446-455. doi: 10.1016/j.toxicon.2010.12.003
Carstens, Bodil B., Clark, Richard J., Daly, Norelle L., Harvey, Peta J., Kaas, Quentin and Craik, David J. (2012). Corrigendum: Engineering of Conotoxins for the Treatment of Pain (Current Pharmaceutical Design, (2011), 17, 38). Current Pharmaceutical Design, 18 (8) doi: 10.2174/138161212799315858
Engineering cyclic peptide toxins
Clark, Richard J. and Craik, David J. (2012). Engineering cyclic peptide toxins. Methods in Enzymology, 503, 57-74. doi: 10.1016/B978-0-12-396962-0.00003-3
Engineering of conotoxins for the treatment of pain
Carstens, Bodil B., Clark, Richard J., Daly, Norelle L., Harvey, Peta J., Kaas, Quentin and Craik, David J. (2011). Engineering of conotoxins for the treatment of pain. Current Pharmaceutical Design, 17 (38), 4242-4253. doi: 10.2174/138161211798999401
Engineering pro-angiogenic peptides using stable disulfide-rich cyclic scaffolds
Chan, Lai Y., Gunasekera, Sunithi, Henriques, Sonia T., Worth, Natalie F., Le, Sarah-Jane, Clark, Richard J., Campbell, Julie H., Craik, David J. and Daly, Norelle L. (2011). Engineering pro-angiogenic peptides using stable disulfide-rich cyclic scaffolds. Blood, 118 (25), 6709-6717. doi: 10.1182/blood-2011-06-359141
Halai, Reena, Callaghan, Brid, Daly, Norelle L., Clark, Richard J., Adams, David J. and Craik, David J. (2011). Effects of cyclization on stability, structure, and activity of alpha-conotoxin RgIA at the alpha 9 alpha 10 nicotinic acetylcholine receptor and GABA(B) receptor. Journal of Medicinal Chemistry, 54 (19), 6984-6992. doi: 10.1021/jm201060r
Wang, Conan K. L., Clark, Richard J., Harvey, Peta J., Rosengren, K. Johan, Cemazar, Masa and Craik, David J. (2011). The role of conserved Glu residue on cyclotide stability and activity: A structural and functional study of kalata B12, a naturally occurring Glu to Asp mutant. Biochemistry, 50 (19), 4077-4086. doi: 10.1021/bi2004153
Haugaard-Kedström, Linda M., Shabanpoor, Fazel, Hossain, Mohammed Akhter, Clark, Richard J., Ryan, Philip J., Craik, David J., Gundlach, Andrew L., Wade, John D., Bathgate, Ross A. D. and Rosengren, K. Johan (2011). Design, synthesis, and characterization of a single-chain peptide antagonist for the relaxin-3 receptor RXFP3. Journal of the American Chemical Society, 133 (13), 4965-4974. doi: 10.1021/ja110567j
Daly, Norelle L., Callaghan, Brid, Clark, Richard J., Nevin, Simon T., Adams, David J. and Craik, David J. (2011). Structure and activity of alpha-conotoxin PeIA at nicotinic acetylcholine receptor subtypes and GABA(B) receptor-coupled N-type calcium channels. Journal of Biological Chemistry, 286 (12), 10233-10237. doi: 10.1074/jbc.M110.196170
Understanding the structure/activity relationships of the iron regulatory peptide hepcidin
Clark, Richard J., Tan, Chia Chia, Preza, Gloria C., Nemeth, Elizabeta, Ganz, Tomas and Craik, David J. (2011). Understanding the structure/activity relationships of the iron regulatory peptide hepcidin. Chemistry and Biology, 18 (3), 336-343. doi: 10.1016/j.chembiol.2010.12.009
Akcan, M, Stroud, MR, Hansen, SJ, Clark, RJ, Daly, NL, Craik, DJ and Olson, JM (2011). Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapy. Journal of Medicinal Chemistry, 54 (3), 782-787. doi: 10.1021/jm101018r
Interlocking Disulfides in Circular Proteins: Toward Efficient Oxidative Folding of Cyclotides
Aboye, Teshome Leta, Clark, Richard J., Burman, Robert, Roig, Marta Bajona, Craik, David J. and Goransson, Ulf (2011). Interlocking Disulfides in Circular Proteins: Toward Efficient Oxidative Folding of Cyclotides. Antioxidants & Redox Signaling, 14 (1), 77-86. doi: 10.1089/ars.2010.3112
Stabilization of α-conotoxin AuIB: Influences of disulfide connectivity and backbone cyclization
Lovelace, Erica S., Gunasekera, Sunithi, Alvarmo, Charlotta, Clark, Richard J., Nevin, Simon T., Grishin, Anton A., Adams, David J., Craik, David J. and Daly, Norelle L. (2011). Stabilization of α-conotoxin AuIB: Influences of disulfide connectivity and backbone cyclization. Antioxidants and Redox Signaling, 14 (1), 87-95. doi: 10.1089/ars.2009.3068
Structural and functional analysis of human liver-expressed antimicrobial peptide 2
Henriques, Sonia Troeira, Tan, Chia Chia, Craik, David J. and Clark, Richard J. (2010). Structural and functional analysis of human liver-expressed antimicrobial peptide 2. ChemBioChem, 11 (15), 2148-2157. doi: 10.1002/cbic.201000400
Isolation, sequencing, and structure - Activity relationships of cyclotides
Ireland, David C., Clark, Richard J., Daly, Norelle L. and Craik, David J. (2010). Isolation, sequencing, and structure - Activity relationships of cyclotides. Journal of Natural Products, 73 (9), 1610-1622. doi: 10.1021/np1000413
The engineering of an orally active conotoxin for the treatment of neuropathic pain
Clark, Richard J., Jensen, Jonas, Nevin, Simon T., Callaghan, Brid P., Adams, David J. and Craik, David J. (2010). The engineering of an orally active conotoxin for the treatment of neuropathic pain. Angewandte Chemie (International Edition), 49 (37), 6545-6548. doi: 10.1002/anie.201000620
Huang, Yen-Hua (黃彥華), Colgrave, Michelle L., Clark, Richard J., Kotze, Andrew C. and Craik, David J. (2010). Lysine-scanning mutagenesis reveals an amendable face of the cyclotide kalata B1 for the optimization of nematocidal activity. Journal of Biological Chemistry, 285 (14), 10797-10805. doi: 10.1074/jbc.M109.089854
Clark, Richard J. and Craik, David J. (2010). Native chemical ligation applied to the synthesis and bioengineering of circular peptides and proteins. Biopolymers, 94 (4), 414-422. doi: 10.1002/bip.21372
Lattin, J. E., Greenwood, K. P., Daly, N. L., Kelly, G, Zidar, D. A., Clark, R. J., Thomas, W. G., Kellie, Stuart, Craik, D. J., Hume, D. A. and Sweet, M. J. (2009). Beta-arrestin 2 is required for complement C1q expression in macrophages and constrains factor-independent survival. Molecular Immunology, 47 (2-3), 340-347. doi: 10.1016/j.molimm.2009.09.012
Armishaw, Christopher J., Singh, Narender, Medina-Franco, Jose L., Clark, Richard J., Scott, Krystle C. M., Houghten, Richard A. and Jensen, Anders A. (2009). A synthetic combinatorial strategy for developing alpha-conotoxin analogs as potent alpha7 nicotinic acetylcholine receptor antagonists. Journal of Biological Chemistry, 285 (3), 1809-1821. doi: 10.1074/jbc.M109.071183
Halai, Reena, Clark, Richard J., Nevin, Simon T., Jensen, Jonas E., Adams, David J. and Craik, David J. (2009). Scanning mutagenesis of alpha-conotoxin Vc1.1 reveals residues crucial for activity at the alpha-9 alpha-10 nicotinic acetylcholine receptor. Journal of Biological Chemistry, 284 (30), 20275-20284. doi: 10.1074/jbc.M109.015339
Dissecting the oxidative folding of circular cystine knot miniproteins
Gunasekera, Sunithi, Daly, Norelle L., Clark, Richard J. and Craik, David J. (2009). Dissecting the oxidative folding of circular cystine knot miniproteins. Antioxidants and Redox Signalling, 11 (5), 971-980. doi: 10.1089/ars.2008.2295
Armishaw, Christopher, Jensen, Anders A., Balle, Thomas, Clark, Richard J., Harpsøe, Kasper, Skonberg, Christian, Liljefors, Tommy and Strømgaard, Kristian (2009). Rational design of alpha-conotoxin analogues targeting alpha 7 nicotinic acetylcholine receptors: Improved antagonistic activity by incorporation of proline derivatives. Journal of Biological Chemistry, 284 (14), 9498-9512. doi: 10.1074/jbc.M806136200
Millard, Emma L., Nevin, Simon T., Loughnan, Marion L., Nicke, Annette, Clark, Richard J., Alewood, Paul F., Lewis, Richard J., Adams, David J., Craik, David J. and Daly, Norelle L. (2009). Inhibition of neuronal nicotinic acetylcholine receptor subtypes by alpha-conotoxin GID and analogues. Journal of Biological Chemistry, 284 (8), 4944-4951. doi: 10.1074/jbc.M804950200
Callaghan, Brid, Haythornthwaite, Alison R., Berecki, Geza, Clark, Richard J., Craik, David J. and Adams, David J. (2008). Analgesic alpha-Conotoxins Vc1.1 and Rg1A inhibit N-type calcium channels in rat sensory neurons via GABA-B receptor activation. The Journal of Neuroscience, 28 (43), 10943-10951. doi: 10.1523/JNEUROSCI.3594-08.2008
Gunasekera, Sunithi, Foley, Fiona M., Clark, Richard J., Sando, Lillian, Fabri, Louis J., Craik, David J. and Daly, Norelle L. (2008). Engineering stablized vascular endothelial growth factor-A antagonists: synthesis, structural characterization and bioactivity of grafted analogues of cyclotides. Journal of Medicinal Chemistry, 51 (24), 7697-7704. doi: 10.1021/jm800704e
Westermann, Jan, Clark, Richard J. and Craik, David J. (2008). Binding mode of alpha-conotoxins to an acetylcholine binding protein determined by saturation transfer difference NMR. Protein And Peptide Letters, 15 (9), 910-914. doi: 10.2174/092986608785849335
The three-dimensional structure of the analgesic alpha-conotoxin, RgIA
Clark, Richard J., Daly, Norelle L., Halai, Reena, Nevin, Simon T., Adams, David J. and Craik, David J. (2008). The three-dimensional structure of the analgesic alpha-conotoxin, RgIA. FEBS Letters, 582 (5), 597-602. doi: 10.1016/j.febslet.2008.01.027
The alpine violet, Viola biflora, is a rich source of cyclotides with potent cytotoxicity
Herrman, Anders, Burman, Robert, Mylne, Joshua S., Karlsson, Gustav, Gullbo, Joachim, Craik, David J., Clark, Richard J. and Goransson, Ulf (2008). The alpine violet, Viola biflora, is a rich source of cyclotides with potent cytotoxicity. Phytochemistry, 69 (4), 939-952. doi: 10.1016/j.phytochem.2007.10.023
Cyclotides and conotoxins ultra-stable disulfide-rich peptides
Craik, David J., Clark, Richard J. and Daly, Norelle L. (2008). Cyclotides and conotoxins ultra-stable disulfide-rich peptides. Chimica Oggi -Chemistry Today, 26 (4), 20-22.
Aboye, T, Clark, Richard J., Craik, David J. and Goransson, U (2008). Utlra-stable peptide scaffolds for protein engineering synthesis and folding of the circular cystine knotted cyclotide cycloviolacin O2. ChemBioChem, 9 (1), 103-113. doi: 10.1002/cbic.200700357
Are alpha 9 alpha 10 nicotinic acetylcholine receptors a pain target for alpha-conotoxins?
Nevin, Simon T., Clark, Richard J., Klimis, H., Christie, M. J., Craik, David J. and Adams, David J. (2007). Are alpha 9 alpha 10 nicotinic acetylcholine receptors a pain target for alpha-conotoxins?. Molecular Pharmacology, 72 (6), 1406-1410. doi: 10.1124/mol.107.040568
Structure of alpha-conotoxin BuIA: Influences of disulfide connectivity on structural dynamics
Jin, Ai-Hua, Brandstaetter, Hemma, Nevin, Simon T., Tan, Chia Chia, Clark, Richard J., Adams, David J., Alewood, Paul F., Craik, David J. and Daly, Norelle L. (2007). Structure of alpha-conotoxin BuIA: Influences of disulfide connectivity on structural dynamics. BMC Structural Biology, 7 (28) 28, 1-13. doi: 10.1186/1472-6807-7-28
Gruber, C. W, Cemazar, M., Clark, R. .J, Horibe, T, Renda, R. F., Anderson, M. A. and Craik, D. J. (2007). A novel plant protein-disulfide isomerase involved in the oxidative folding of cystine knot defense proteins. Journal of Biological Chemistry, 282 (28), 20435-20446. doi: 10.1074/jbc.M700018200
Potential therapeutic applications of the cyclotides and related cystine knot mini-proteins
Craik, D. J, Clark, R. J and Daly, N. L (2007). Potential therapeutic applications of the cyclotides and related cystine knot mini-proteins. Expert Opinion On Investigational Drugs, 16 (5), 595-604. doi: 10.1517/13543784.16.5.595
Gunasekera, S, Daly, NL, Clark, RJ, Simonsen, SM, Foley, FM, Saska, I, Lin, F, Wade, JD, Anderson, MA and Craik, DJ (2007). The conserved N-terminal repeat of the plant cyclotides does not assist folding of cyclotide precursor in vitro. Biopolymers, 88 (4), 540-540.
Plan, M. R. R, Goransson, U, Clark, R. J, Daly, N. L, Colgrave, M. L and Craik, D.J (2007). The cyclotide fingerprint in Oldenlandia affinis: Elucidation of chemically modified, linear and novel macrocyclic peptides. Chembiochem, 8 (9), 1001-1011. doi: 10.1002/cbic.200700097
The Synthesis, Structural Characterization, and Receptor Specificity of the {alpha}-Conotoxin Vc1.1
Clark, Richard J., Fischer, Harald, Nevin, Simon T., Adams, David J. and Craik, David J. (2006). The Synthesis, Structural Characterization, and Receptor Specificity of the {alpha}-Conotoxin Vc1.1. Journal of Biological Chemistry, 281 (32), 23254-23263. doi: 10.1074/jbc.M604550200
Daly, N. L., Clark, R. J., Plan, M. R. and Craik, D. J. (2006). Kalata B8, a novel antiviral circular protein, exhibits conformational flexibility in the cystine knot motif. Biochemical Journal, 393 (Part 3), 619-626. doi: 10.1042/BJ20051371
Clark, R. J., Daly, N. L. and Craik, D. J. (2006). Structural plasticity of the cyclic-cystine-knot framework: implications for biological activity and drug design. Biochemical Journal, 394 (Part 1), 85-93. doi: 10.1042/BJ20051691
Daly, N. L., Chen, Y. K., Foley, F. M., Bansal, P. S., Bharathi, R., Clark, R. J., Sommerhoff, C. P. and Craik, D. J. (2006). The absolute structural requirement for a proline in the P3 '-position of Bowman-Birk protease inhibitors is surmounted in the minimized SFTI-1 scaffold. Journal of Biological Chemistry, 281 (33), 23668-23675. doi: 10.1074/jbc.M601426200
Korsinczky, M. L. J., Clark, R. J. and Craik, D. J. (2005). Disulfide bond mutagenesis and the structure and function of the head-to-tail macrocyclic trypsin inhibitor SFTI-1. Biochemistry, 44 (4), 1145-1153. doi: 10.1021/bi048297r
Clark, R. J., Fischer, H., Dempster, L., Daly, N. L., Rosengren, K. J., Nevin, S. T., Meunier, F. A., Adams, D. J. and Craik, D. J. (2005). Engineering stable peptide toxins by means of backbone cyclization: Stabilization of the alpha-conotoxin MII. Proceedings of The National Academy of Sciences of The United States of America, 102 (39), 13767-13772. doi: 10.1073/pnas.0504613102
Dutton, J. L., Renda, R. F., Waine, C., Clark, R. J., Daly, N. L., Jennings, C. V., Anderson, M. A. and Craik, D. J. (2004). Conserved structural and sequence elements implicated in the processing of gene-encoded circular proteins. Journal of Biological Chemistry, 279 (45), 46858-46867. doi: 10.1074/jbc.M407421200
Daly, N. L., Clark, R. J. and Craik, D. J. (2003). Disulfide folding pathways of cystine knot proteins: Tying the knot within the circular backbone of the cyclotides. The Journal of Biological Chemistry, 278 (8), 6314-6322. doi: 10.1074/jbc.M210492200
Diversity in the disulfide folding pathways of cystine knot peptides
Daly, N. L., Clark, R. J., Goransson, U. and Craik, D. J. (2003). Diversity in the disulfide folding pathways of cystine knot peptides. Letters in Peptide Science, 10 (5-6), 523-531. doi: 10.1007/BF02442584
Barry, D. G., Daly, N. L., Clark, R. J., Sando, L. and Craik, D. J. (2003). Linearization of a naturally occurring circular protein maintains structure but eliminates hemolytic activity. Biochemistry, 42 (22), 6688-6695. doi: 10.1021/bi027323n
Rosengren, K. J., Clark, R. J., Daly, N. L., Goransson, U., Jones, A. and Craik, D. J. (2003). Microcin J25 has a threaded sidechain-to-backbone ring structure and not a head-to-tail cyclized backbone. Journal of the American Chemical Society, 125 (41), 12464-12474. doi: 10.1021/JA0367703
Structure-function studies of the plant cyclotides: The role of a circular protein backbone
Craik, David J., Barry, Daniel G., Clark, Richard J., Daly, Norelle L. and Sando, Lillian (2003). Structure-function studies of the plant cyclotides: The role of a circular protein backbone. Toxin Reviews, 22 (4), 555-576. doi: 10.1081/TXR-120026914
Structure-function studies of the plant cyclotides: the role of a circular protein backbone
Craik, David J., Barry, Daniel G., Clark, Richard J., Daly, Norelle L. and Sando, Lillian (2003). Structure-function studies of the plant cyclotides: the role of a circular protein backbone. Journal of Toxicology: Toxin Reviews, 22 (4), 555-576. doi: 10.1081/TXR-120026914
A sponge allelochemical induces ascidian settlement but inhibits metamorphosis
Green, K. M., Russell, B. D., Clark, R. J., Jones, M. K ., Garson, M. J., Skilleter, G. A. and Degnan, B. M. (2002). A sponge allelochemical induces ascidian settlement but inhibits metamorphosis. Marine Biology, 140 (2), 355-363. doi: 10.1007/s002270100698
Discovery and structures of the cyclotides: novel macrocyclic peptides from plants
Craik, David J., Anderson, Marilyn A., Barry, Daniel G., Clark, Richard J., Daly, Norelle L., Jennings, Cameron V. and Mulvenna, Jason P. (2001). Discovery and structures of the cyclotides: novel macrocyclic peptides from plants. Letters in Peptide Science, 8 (3-5), 119-128. doi: 10.1007/BF02446507
Antifungal alkyl amino alcohols from the tropical marine sponge Haliclona n. sp.
Clark, R. J., Garson, M. J. and Hooper, J. N. A. (2001). Antifungal alkyl amino alcohols from the tropical marine sponge Haliclona n. sp.. Journal of Natural Products, 64 (12), 1568-1571. doi: 10.1021/np010246x
Vinylfurans revisited: A new sesquiterpene from Euryspongia deliculata (vol 62, pg 915, 1999)
Clark, Richard J., Garson, Mary J., Brereton, Ian M. and Kennedy, John A. (2000). Vinylfurans revisited: A new sesquiterpene from Euryspongia deliculata (vol 62, pg 915, 1999). Journal of Natural Products, 63 (7), 1046-1046. doi: 10.1021/np0001934
Clark, Richard J., Stapleton, Bronwin L. and Garson, Mary J. (2000). New Isocyano and Isothiocyanato Terpene Metabolites from the Tropical Marine Sponge Acanthella cavernosa. Tetrahedron, 56 (19), 3071-3076. doi: 10.1016/S0040-4020(00)00226-X
Vinylfurans revisited: A new sesquiterpene from Euryspongia deliculata
Clark, R. J., Garson, M. J., Brereton, I. M. and Kennedy, J. A. (1999). Vinylfurans revisited: A new sesquiterpene from Euryspongia deliculata. Journal of Natural Products, 62 (6), 915-916. doi: 10.1021/np980557g
The haliclonacyclamines, cytotoxic tertiary alkaloids from the tropical marine sponge Haliclona sp
Clark, Richard J., Field, Kim L., Charan, Romila D., Garson, Mary J., Brereton, Ian M. and Willis, Anthony C. (1998). The haliclonacyclamines, cytotoxic tertiary alkaloids from the tropical marine sponge Haliclona sp. Tetrahedron, 54 (30), 8811-8826. doi: 10.1016/S0040-4020(98)00473-6
WS1.4: Biostimulation of bacteria for streamlined identification of new antimicrobial compounds
Mirzaee, Hooman, Ariens, Emily, Booth, James, Carvalhais, Lilia C., Blaskovich, Mark A.T., Clark, Richard J. and Schenk, Peer M. (2022). WS1.4: Biostimulation of bacteria for streamlined identification of new antimicrobial compounds. 32nd International Congress of Antimicrobial Chemotherapy (ICC), Perth, WA Australia, 27 – 30 November 2022. Amsterdam, Netherlands: Elsevier BV. doi: 10.1016/s2213-7165(22)00272-7
The antiproliferative profile of a linear octopus-derived peptide in melanoma of BRAF-mutation
Fernandez-Rojo, Manuel A., Brust, Andreas, Potriquet, Jeremy, Daley, Joshua, Ragnarsson, Lotten, Andersson, Asa, Mukhopadhyay, Pamela, Wilhelm, Patrick, Chin, Yanni, Smallwood, Taylor, Clark, Richard, King, Glenn, Ramm, Grant, Waddell, Nic, Lewis, Richard, Boyle, Glen, Fry, Bryan, Alewood, Paul, Mulvenna, Jason, Miles, John and Ikonomopoulou, Maria P. (2020). The antiproliferative profile of a linear octopus-derived peptide in melanoma of BRAF-mutation. 20th World Congress of the International Society on Toxinology, Buenos Aires, Argentina, 8-13 September 2019. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.toxicon.2019.10.014
Motor neuron disease proteins activate complement and generate C5a
Deora, Vandana, Mantovani, Susanna, Yerbury, Justin, Clark, Richard, Atkin, Julie, Lee, John, Gordon, Richard and Woodruff, Trent M. (2017). Motor neuron disease proteins activate complement and generate C5a. 16th European Meeting on Complement in Human Disease (EMCHD), Copenhagen, Denmark, 8-12 September 2017. Kidlington, Oxford, United Kingdom: Pergamon Press. doi: 10.1016/j.molimm.2017.06.144
Development of peptide therapeutics for iron disorders
Goncalves, Daniela, Rishi, Gautam, Aliyanto, Randy, Rosengren, Johan, Subramaniam, Nathan, Frazer, David and Clark, Richard (2016). Development of peptide therapeutics for iron disorders. 6th Meeting of the International BioIron Society, Zhejiang University, Hangzhou, China, 8-10 September 2015. Hoboken, NJ, United States: John Wiley & Sons.
Discovery, Synthesis and Characterization of Novel Cysteine-Rich Peptides From Insects
Koehbach, J. and Clark, R. J. (2016). Discovery, Synthesis and Characterization of Novel Cysteine-Rich Peptides From Insects. HOBOKEN: WILEY.
Keov, P., Liutkeviciute, Z., Clark, R. and Gruber, C. (2016). Pharmacological Characterisation of the Cyclotide Kalata B7 At Insect Orthologues of the Oxytocin/vasopressin Receptors. HOBOKEN: WILEY.
Exploring the chemistry and pharmacological potential of bioactive peptides from insects
Koehbach, Johannes and Clark, Richard J. (2015). Exploring the chemistry and pharmacological potential of bioactive peptides from insects. 14th International Congress on Amino Acids, Peptides and Proteins, Vienna, Austria, August 3–7, 2015. Wien, Austria: Springer Wien. doi: 10.1007/s00726-015-2016-z
A new target for the alpha-conotoxins: the gaba(b) receptor
Clark, R. J., Carstens, B. B., Berecki, G., Callaghan, B., Adams, D. J. and Craik, D. J. (2014). A new target for the alpha-conotoxins: the gaba(b) receptor. Oxford, United Kingdom: John Wiley & Sons.
Applications of conotoxins for the treatment of pain
Craik, David J., Clark, Richard J. and Poth, Aaron (2014). Applications of conotoxins for the treatment of pain. 247th National Spring Meeting of the American Chemical Society (ACS), Dallas, TX, United States, March 16-20, 2014. Washington, DC, United States: American Chemical Society.
Development of analgesic alpha-conotoxins for treatment of chronic pain
Adams, D. J., Berecki, G., Clark, R. and Craik, D. J. (2013). Development of analgesic alpha-conotoxins for treatment of chronic pain. 4th Meeting of the Australia Chinese Association for Biomedical Sciences Inc (ACABS), Hangzhou Peoples R China, 10-13 October 2013. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/1440-1681.12170
Kompella, Shiva N., Hung, Andrew, Clark, Richard J. and Adams, David J. (2013). alpha-Conotoxin Regiia Targeting Nicotinic Acetylcholine Receptors: Mutagenesis Studies Improving Selectivity and Potency. 57th Annual Meeting of the Biophysical Society, Philadelphia Pa, 02-06 February 2013. Maryland Heights, MO United States: Cell Press. doi: 10.1016/j.bpj.2012.11.3505
Engineering pro-angiogenic peptides using stable disulfide-rich scaffolds
Chan, L. A., Gunasekera, S., Henriques, S. T., Worth, N. F., Le, S., Clark, R. J., Campbell, J. H., Craik, D. J. and Daly, N. L. (2012). Engineering pro-angiogenic peptides using stable disulfide-rich scaffolds. 32nd European Peptide Symposium, Athens, Greece, 2-7 September 2012. Chichester, West Sussex, United Kingdom: John Wiley & Sons. doi: 10.1002/psc.2448
Novel single-chain ligands for the relaxin-3 receptor RXFP3
Rosengren, K. J., Haugaard-Kedstroem, L. M., Jones, M., Clark, R. J. and Bathgate, R. A. D. (2012). Novel single-chain ligands for the relaxin-3 receptor RXFP3. 32nd European Peptide Symposium "Peptides 2012", Athens, Greece, 02-07 September 2012. West Sussex, United Kingdom: John Wiley and Sons. doi: 10.1002/psc.2448
Understanding the structure/activity relationships of the iron regulatory peptide hepcidin
Clark, R. J., Tan, C., Preza, G. C., Nemeth, E., Ganz, T. and Craik, D. J. (2012). Understanding the structure/activity relationships of the iron regulatory peptide hepcidin. 32nd European Peptide Symposium "Peptides 2012", Athens, Greece, 2-7 September 2012. West Sussex, United Kingdom: John Wiley and Sons. doi: 10.1002/psc.2448
Adams, D. J., Grishin, A. A., Hung, A., Clark, R. J., Akondi, K., Alewood, P. F. and Craik, D. J. (2011). Scanning mutagenesis of alpha-conotoxin AuIB reveals a critical residue for activity at the alpha-3-beta-4 nicotinic acetylcholine receptor. nAChR2011: Nicotinic Acetylcholine Receptors as Therapeutic Targets: Emerging Frontiers in Basic Research & Clinical Science, Washington, DC, U.S.A., 9-11 November 2011. Philadelphia, PA, U.S.A.: Elsevier. doi: 10.1016/j.bcp.2011.07.017
Evaluation of toxicity and antitumor activity of cycloviolacin O2 in mice
Burman, Robert, Svedlund, Erika, Felth, Jenny, Hassan, Saadia, Hermann, Anders, Clark, Richard James, Craik, David J., Bohlin, Lars, Claeson, Per, Goransson, Ulf and Gullbo, Joachim (2010). Evaluation of toxicity and antitumor activity of cycloviolacin O2 in mice. 1st International Conference on Circular Proteins, Heron Island, Qld, Australia, 18-21 October, 2009. Hoboken, NJ, U.S.A: Wiley Interscience. doi: 10.1002/bip.21408
Sunflower trypsin inhibitor-1, proteolytic studies on a trypsin inhibitor peptide and its analogs
Colgrave, Michelle, Korsinczky, Michael Laszlo Jonas, Clark, Richard James, Foley, Fiona and Craik, David J. (2010). Sunflower trypsin inhibitor-1, proteolytic studies on a trypsin inhibitor peptide and its analogs. 1st International Conference on Circular Proteins, Heron Island, Qld, Australia, 18-21 October 2009. Hoboken, N.J., U.S.: John Wiley & Sons. doi: 10.1002/bip.21415
The engineering of an orally active conotoxin for the treatment of neuropathic pain
Clark, J., Jensen, J., Nevin, S., Brid, C., Adams, D. and Craik, D. (2010). The engineering of an orally active conotoxin for the treatment of neuropathic pain. EPS 2010: The 31st European Peptide Symposium, Copenhagen, Denmark, 5-9 September 2010. Bognor Regis, West Sussex, U.K.: John Wiley & Sons. doi: 10.1002/psc.1302
Mutational atudies on alpha-conotoxin VCL1
Halai, R., Clark, R., Nevin, S., Adams, D. and Craik, D. (2009). Mutational atudies on alpha-conotoxin VCL1. 21st American Peptide Symposium, Bloomington, Indiana, USA, 7-12 June 2009. United States: John Wiley & Sons, Inc.. doi: 10.1002/bip.21223
Structural Aspects of Hepcidin-Ferroportin Binding
Preza, G, Fernandes, A, Clark, RJ, Craik, DJ, Ganz, T and Nemeth, E (2008). Structural Aspects of Hepcidin-Ferroportin Binding. 50th Annual Meeting of the American- Society-of-Hematology, San Francisco Ca, Dec 06-09, 2008. WASHINGTON: AMER SOC HEMATOLOGY.
Synthesis and folding of the circular cystine knotted cyclotide cycloviolacin O2
Aboye, Teshome, Clark, Richard, Craik, David J. and Goransson, Ulf (2008). Synthesis and folding of the circular cystine knotted cyclotide cycloviolacin O2. 30th European Peptide Symposium (30EPS), Helsinki, Finland, 31 August – 5 September 2008. United Kingdom: John Wiley & Sons Ltd.. doi: 10.1002/psc.1090
Synthesis and folding of the circular cystine knotted cyclotide cycloviolacin O2
Aboye, Teshome, Clark, Richard, Craik, David J. and Goransson, Ulf (2008). Synthesis and folding of the circular cystine knotted cyclotide cycloviolacin O2. 7th Joint Meeting of GA, AFERP, ASP, PSE & SIF, Athens, Greece, 3-8 August 2008. Germany: Georg Thieme Verlag.
Understanding the structure/activity relationships of hepcidin
Clark, Richard, Tan, Chia Chia, Nemeth, Elizabeta, Ganz, Thomas and Craik, David (2008). Understanding the structure/activity relationships of hepcidin. 30th European Peptide Symposium (30EPS), Helsinki, Finland, 31 August – 5 September 2008. United Kingdom: John Wiley & Sons Ltd.. doi: 10.1002/psc.1090
Gruber, G. W., Cemazar, M., Clark, R., Horibe, T., Renda, R., Anderson, M. A. and Craik, D. J. (2007). Enzyme mechanism and function of a novel plant protein disulfide isomerase involved in the oxidative folding of cystine knot defence peptides. 20th American-Peptide-Society Symposium, Montréal, Canada, 26-30 Jun 2007. Hoboken, N. J., U.S.: John Wiley & Sons. doi: 10.1002/bip.20783
A novel threaded ring structure for the antimicrobial peptide microcin J25
Rosengren, KJ, Jen, FEC, Clark, RJ, Goransson, U, Daly, NL and Craik, DJ (2005). A novel threaded ring structure for the antimicrobial peptide microcin J25. Peptides 2004: 3rd International Peptide Symposium / 28th European Peptide Symposium, Prague, Czech Republic, 5 - 10 September 2004. Geneva, Switzerland: Kenes International.
A novel threaded ring structure for the antimicrobial peptide microcin J25
Craik, D. J., Rosengren, K. J., Clark, R. J., Daly, N. L. and Goransson, U. (2004). A novel threaded ring structure for the antimicrobial peptide microcin J25. 3rd International and 28th European Peptide Symposium, Prague, Czech Republic, 5–10 September 2004. West Sussex, United Kingdom: John Wiley & Sons. doi: 10.1002/psc.617
Cyclotides: Novel Peptidic Pesticides for Plant Protection
Plan, MR, Goransson, U, Rosengren, KJ, Clark, RJ, Daly, NL, Evert, P, Chen, C, Cagauan, AG and Craik, DJ (2004). Cyclotides: Novel Peptidic Pesticides for Plant Protection. CHICHESTER: JOHN WILEY & SONS LTD.
Design, Synthesis and Structural Studies of Cyclic Alpha-Conotoxins
Clark, RJ, Dempster, L, Daly, NL, Rosengren, KJ and Craik, DJ (2004). Design, Synthesis and Structural Studies of Cyclic Alpha-Conotoxins. CHICHESTER: JOHN WILEY & SONS LTD.
Probing nucleotide dissociation from myosin in vitro using microgram quantities of myosin
Clark, Richard J., Nyitrai, Miklós, Webb, Martin R. and Geeves, Michael A. (2003). Probing nucleotide dissociation from myosin in vitro using microgram quantities of myosin.
Sponge allelochemical induces ascidian development but inhibits metamorphosis
Green, K., Russell, B. D., Clark, R., Jones, M. K., Skilleter, G. A., Garson, M. J. and Degnan, B. M. (2002). Sponge allelochemical induces ascidian development but inhibits metamorphosis. 23rd International Conference on Natural Products, Italy, July, 2002.
Sponge alleleochemical induces ascidian settlement but inhibits metamorphosis
Green, K., Russell, B. D., Clark, R. J., Jones, M. K., Skilleter, G. A., Garson, M. J. and Degnan, B. M. (2001). Sponge alleleochemical induces ascidian settlement but inhibits metamorphosis. 3rd IUPAC International Conference on Biodiversity, Turkey, 2001. Antalya, Turkey:
Sponge allelochemical induces ascidian development but inhibits metamorphosis
Clark, R. J., Degnan, B. M., Garson, M. J., Green, K. M., Jones, M. K., Russell, B. D. and Skilleter, G. A. (2001). Sponge allelochemical induces ascidian development but inhibits metamorphosis. The World Chemistry Congress 2001, Brisbane, Australia, 106 July 2001.
Marine ecology: The natural approach to finding bioactives
Garson, M. J., Blunt, J. W., Clark, R., Degnan, B. M., Green, K. M., Munro, M. H., Simpson, J. and Skilleter, G. A. (2000). Marine ecology: The natural approach to finding bioactives. Australasian Biotechnological Association Conference, Brisbane, 2-6 July, 2000.
Sponge allelochemical induces ascidian development but inhibits metamorphosis
Green, K. M., Russell, B. D., Clark, R., Jones, M. K., Skilleter, G. A., Garson, M. J. and Degnan, B. M. (2000). Sponge allelochemical induces ascidian development but inhibits metamorphosis. Pacifichem 2000, Honolulu, Hawaii, USA, 14-19 December, 2000.
Garson, M. J., Clark, R., Webb, R. I., Field, K. L. and Charan, R. D. (1999). Ecological role of cytotoxic alkaloids: Haliclona n.sp., an unusual sponge/dinoflagellate association. 5th International Sponge Conference, Brisbane, 27 June - 4 July 1999. Brisbane: Qld Museum.
The chemistry and chemical ecology of marine sponges
Clark, Richard James (2000). The chemistry and chemical ecology of marine sponges. PhD Thesis, School of Molecular and Microbial Sciences, The University of Queensland.
Making peptides orally bioavailable
(2022–2025) ARC Discovery Projects
Making peptide drugs orally bioavailable
(2022–2024) NHMRC IDEAS Grants
(2022–2024) NHMRC Development Grant
(2022–2023) Multiple Sclerosis Research Australia - Targeted Grant - Neurodegeneration
Complement C5aR1: A novel therapeutic target for brain cancer
(2021–2023) Brain Cancer Innovation Project Grants
(2020–2023) Cure for MND Foundation - Drug Development Grants
Neuroprotective role of novel acid-sensing ion channel inhibitor in Multiple sclerosis (MS) disease
(2020–2022) Multiple Sclerosis Research Australia
(2019) UQ Major Equipment and Infrastructure
(2019) UQ Major Equipment and Infrastructure
(2018) UQ Major Equipment and Infrastructure
Preclinical Development of Complement C5aR Antagonists for the Treatment of Motor Neuron Disease
(2017–2021) NHMRC Development Grant
(2017–2019) University of Sydney
A Pharmacology Screening Facility to Accelerate Drug Discovery and Development
(2017–2018) UQ Major Equipment and Infrastructure
Development of complement C5aR1 antagonists for the treatment of motor neuron disease
(2016–2017) UQ Collaboration and Industry Engagement Fund - FirstLink
Integrative blood coagulation research core facility
(2016) UQ Major Equipment and Infrastructure
Patch-clamp electrophysiology platform for drug and insecticide discovery
(2016) UQ Major Equipment and Infrastructure
Better treatments for chronic pain
(2014–2016) NHMRC Development Grant
(2012–2015) Royal Melbourne Institute of Technology University
Development of effective peptide-based drugs
(2011–2015) ARC Future Fellowships
Understanding the structure/function relationships of the iron regulatory peptide hepcidin
(2011–2014) NHMRC Project Grant
Elucidating the neuroprotective properties of alpha-conotoxins
(2011–2012) UQ New Staff Research Start-Up Fund
A Multi-Channel Fluorescence Plate Reader for Studying Receptor-Ligand Interactions
(2011) NHMRC Equipment Grant
Building UQ's analytical capacity in biomedical sciences
(2011) UQ Major Equipment and Infrastructure
A new G-protein coupled receptor target for conotoxins
(2010–2012) ARC Discovery Projects
New peptide-based drugs for the treatment of neuropathic pain
(2010–2012) NHMRC Project Grant
The development of peptides (mini-proteins) as drugs: improved purification capability
(2010) UQ Major Equipment and Infrastructure
Cone Shell snail venom research
(2009–2021) The Simon Axelsen Memorial Fund
NHMRC Career Development Award (Biomedical - Level 1): Development of effective peptide-based drugs
(2008–2011) NHMRC Career Development Award
Development of a novel orally active peptide for the treatment of pain
(2008–2010) NHMRC Development Grant
Discovery of novel cyclotides.
(2008–2010) Department of Innovation, Industry, Science and Research
Development of a generic strategy for the stabilisation of peptide-based therapeutics
(2007–2010) NHMRC Project Grant
Novel peptides for the treatment of pain
(2007–2010) NHMRC Project Grant
Development of stable peptide-based drugs for the treatment of iron disorders
(2007–2008) UQ Early Career Researcher
Exploring the therapeutic potential of a novel family of proteins
(2007) Australian Academy of Science
Molecular imprinting of circular proteins
(2007) UQ Travel Grants Scheme
Design and development of peptide ligands targeting the complement system
Doctor Philosophy — Principal Advisor
Other advisors:
Making peptide drugs orally bioavailable
Doctor Philosophy — Principal Advisor
Other advisors:
A novel cyclic peptide scaffold for drug design applications
Doctor Philosophy — Associate Advisor
Other advisors:
Novel long-acting and orally delivered conotoxin-based peptides with both analgesic efficacy and disease modifying potential
Doctor Philosophy — Associate Advisor
Other advisors:
Insights into Protein Modification by Nuclear Magnetic Resonance Spectroscopy
Master Philosophy — Associate Advisor
Other advisors:
Preclinical evaluation of complement receptor targeted drugs for neurological disease
Doctor Philosophy — Associate Advisor
Other advisors:
Design and Development of Peptides Targeting the C5a-C5aR Interaction
(2022) Doctor Philosophy — Principal Advisor
Other advisors:
Development of miniaturised alpha-conotoxins for the treatment of pain
(2020) Doctor Philosophy — Principal Advisor
Other advisors:
Mining helminth secretions for new classes of immune suppressing drugs
(2019) Doctor Philosophy — Principal Advisor
Other advisors:
Development of Peptide Therapeutics for Iron Disorders
(2018) Doctor Philosophy — Principal Advisor
Other advisors:
Marine natural wonders and the beginning of their journey towards the pharmaceutical market
(2014) Doctor Philosophy — Principal Advisor
Other advisors:
(2022) Doctor Philosophy — Associate Advisor
Other advisors:
Structural Studies of Peptides Buried within Seed Storage Proteins
(2022) Doctor Philosophy — Associate Advisor
Other advisors:
Investigating the Immunopharmacology of the Complement C5a Receptors, C5aR1 and C5aR2
(2021) Doctor Philosophy — Associate Advisor
Other advisors:
Targeting of relaxin-3 analogues to the brain for pharmacological modulation of neurosignalling
(2020) Doctor Philosophy — Associate Advisor
Other advisors:
Expanding the Structural Atlas of Peptide Toxins
(2019) Doctor Philosophy — Associate Advisor
Other advisors:
Structural insights into cyclic plant peptides and their albumin precursors
(2017) Doctor Philosophy — Associate Advisor
Other advisors:
The Science and Business of Novel Therapeutics: The Need for a Complete Picture
(2015) Doctor Philosophy — Associate Advisor
Other advisors:
PEPLINK: A Fragment-Based Method for Screening Peptides as Drug Leads
(2012) Doctor Philosophy — Associate Advisor
Other advisors:
Design and discovery of cyclic peptides with applications in drug development
(2011) Doctor Philosophy — Associate Advisor
Other advisors:
The story of a-conotoxins, Vc1.1 and RgIA, on their journey to becoming therapeutics
(2010) Doctor Philosophy — Associate Advisor
Other advisors:
Note for students: The possible research projects listed on this page may not be comprehensive or up to date. Always feel free to contact the staff for more information, and also with your own research ideas.
Designing novel conotoxins with therapeutic potential
Conotoxins, with their exquisite specificity and potency have recently created much excitement as drug leads for the treatment of chronic pain. For example, the conotoxin MVIIA (also known as Ziconotide or Prialt) has been approved for use in the U.S. and Europe for the treatment of pain and several other conotoxins have entered clinical trials. In addition, a number of conotoxins have played a critical role in dissecting the molecular mechanisms of ion channel and transporter functions in the nervous system.
There are projects available in the design of novel conotoxins that target specific receptors involved in pain.
Development of stable peptide-based drugs for the treatment of iron disorders
Hepcidin is the principal iron-regulatory hormone and the key mediator of iron overload (haemochromatosis) and anaemia of inflammation. This research project involves two development streams of peptide design, synthesis and structure/function analysis. The first stream will focus on the specific residues important for biological activity of hepcidin and the mutation of these residues to improve activity. The second stream will involve the development of stabilised analogues of native hepcidin. The two streams will coalesce during the final round of development to produce a series of novel cyclic hepcidin drug leads.